by Plus Therapeutics | Apr 9, 2024 | Uncategorized
We would like to officially welcome Neuro-Oncologist Andrew Brenner, M.D., Ph.D. and Barbara Blouw, Ph.D. to the Plus Therapeutics Management Team! “As we prepare for the future, Plus is substantially strengthening its management in key areas such as cancer biology,...
by Plus Therapeutics | Apr 8, 2024 | LM
Our ReSPECT-LM Poster from the National Comprehensive Network (NCCN) Conference is now on our website at https://ir.plustherapeutics.com/presentations
by Plus Therapeutics | Apr 5, 2024 | LM
Visit our poster at the National Comprehensive Cancer Network® (NCCN®) conference today and say hello to our clinical team! The poster will be available on our website after the conference
by Plus Therapeutics | Apr 3, 2024 | GBM
Plus Therapeutics’ novel approach to treating Glioblastoma overcomes the limitations of all three currently employed treatment modalities. Leveraging established, targeted delivery techniques, we seek to inject high doses of radiation directly into or near a...
by Plus Therapeutics | Apr 2, 2024 | Uncategorized
We are pleased to introduce Frank Gonzalez Rodriguez as Senior Clinical Trial Associate at Plus Therapeutics! He is looking forward to being on the sponsor side of our clinical trials and part of our clinical operations team....
Recent Comments